Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes | Aplastic Anemia & MDS International Foundation Return to top.

Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes

Journal Title: 
Annals of internal medicine
Primary Author: 
Angelucci E
Author(s): 
Angelucci E, Greenberg P, Izquierdo M, Garcia-Manero G
Original Publication Date: 
Tuesday, October 6, 2020
Bone Marrow Disease(s): 
  • myelodysplastic syndromes (MDS)
Share with addtoany.com.